DELETERIOUS PALB2 GENE MUTATION
Clinical trials for DELETERIOUS PALB2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new DELETERIOUS PALB2 GENE MUTATION trials appear
Sign up with your email to follow new studies for DELETERIOUS PALB2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against hereditary breast cancer
Disease control OngoingThis study tests two drugs, niraparib and dostarlimab, given before surgery to people with BRCA- or PALB2-mutated breast cancer. The goal is to see if this combination boosts the immune system's attack on the tumor and leads to a complete response (no cancer left at surgery). Abo…
Matched conditions: DELETERIOUS PALB2 GENE MUTATION
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Which surgery best prevents ovarian cancer without harming sexual health?
Prevention OngoingThis study looks at two types of surgery to prevent ovarian cancer in women aged 30-50 who have gene mutations that raise their risk. One surgery removes both the fallopian tubes and ovaries, while the other removes only the tubes first and delays removing the ovaries. The goal i…
Matched conditions: DELETERIOUS PALB2 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC